Bayer Will Invest $30M in Joint Research Lab for Chronic Lung Diseases
Bayer will invest more than $30 million over the next five years to fund collaborative research projects focused on finding new treatments for chronic lung diseases, including chronic obstructive pulmonary disease (COPD). The projects will be developed in a new lab launched in collaboration with the founding members of…